Dr. David Lim obtained his Ph.D. in biological sciences at the University of Missouri-Columbia in 1993. Since then, Dr. Lim has held various positions at Duke University Medical Center, US National Laboratories, Intrexon Corporation, Terumo and Center for Devices and Radiological Health (CDRH) at US Food and Drug Administration (FDA). In addition, Dr. Lim, as a licensed patent practitioner before the US Patent and Trademark Office (USPTO), had prosecuted numerous biotechnology patent applications leading to patent issuance. Currently, Dr. Lim is Senior Vice President of Scientific and Regulatory Affairs at Aquavit Pharmaceuticals, Inc., in New York. Prior to Aquavit Pharmaceuticals, Dr. Lim served as Director of Regulatory Affairs at EraGen Biosciences, Inc., A Luminex Company in Madison, WI. Dr. Lim is a certified professional for regulatory affairs (RAC) and also is a certified quality auditor (CQA) by the American Society for Quality (ASQ). Dr. Lim is a seasoned auditor, consultant and instructor for global regulatory, clinical and quality matters. Dr. Lim is about to pursue his final year in law school.